Back to top
more

DaVita (DVA)

(Real Time Quote from BATS)

$139.10 USD

139.10
289,263

+1.38 (1.00%)

Updated Jul 17, 2024 02:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.

Veeva (VEEV) Vault QMS Gets Picked by Samsung Biologics

by Zacks Equity Research

Veeva Systems' (VEEV) Vault Quality Suite gets selected by Samsung Biologics to drive quality process and content management for better visibility across the latter's global processes.

    Should Value Investors Buy DaVita HealthCare (DVA) Stock?

    by Zacks Equity Research

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    Masimo (MASI) Releases Favorable Findings on Pulse Oximetry

    by Zacks Equity Research

    Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.

    Encompass Health (EHC) to Spin Off Unit to Streamline Business

    by Zacks Equity Research

    Encompass Health (EHC) is exploring strategic alternatives to split its home health and hospice business from the original corporate structure to streamline operations.

    DVA vs. CHE: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    DVA vs. CHE: Which Stock Is the Better Value Option?

    Should Value Investors Buy DaVita HealthCare (DVA) Stock?

    by Zacks Equity Research

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    Should Value Investors Choose DaVita (DVA) Stock Now?

    by Zacks Equity Research

    Is DaVita (DVA) a great pick from the value investor's perspective right now? Read on to know more.

    Why DaVita (DVA) Could Be an Impressive Growth Stock

    by Zacks Equity Research

    If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider DaVita (DVA).

    DaVita's (DVA) Shares March Higher, Can It Continue?

    by Zacks Equity Research

    As of late, it has definitely been a great time to be an investor in DaVita (DVA).

    DVA or CHE: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    DVA vs. CHE: Which Stock Is the Better Value Option?

    Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

    by Zacks Equity Research

    Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.

      Allscripts' (MDRX) Veradigm Collaborates With HealthVerity

      by Zacks Equity Research

      Allscripts (MDRX) and HealthVerity will be committed toward catering to specific industry needs by helping clients design linked data solutions that are fit-for-purpose.

      Here's Why You Should Hold NextGen (NXGN) in Your Portfolio Now

      by Zacks Equity Research

      Investor optimism is high on NextGen (NXGN) stock, thanks to solid prospects.

      AngioDynamics (ANGO) Shows Solid Results from RAPID Database

      by Zacks Equity Research

      The RAPID study proved that AngioDynamics' (ANGO) AngioVac System was versatile, safe and effective for the removal of vascular thrombi and cardiac masses.

      Is DaVita (DVA) Outperforming Other Medical Stocks This Year?

      by Zacks Equity Research

      Is (DVA) Outperforming Other Medical Stocks This Year?

      Ecolab Introduces Exelerate TUFSOIL for Food Manufacturers

      by Zacks Equity Research

      Ecolab's (ECL) Exelerate TUFSOIL has been developed to increase production time and enhance cleaning outcomes to curb food safety risks and improve worker safety.

      Becton Dickinson (BDX) Buys Medical Business Assets of CUBEX

      by Zacks Equity Research

      This should further boost BD's (BDX) Medical segment.

      Encompass Health (EHC) to Build Rehabilitation Hub in Illinois

      by Zacks Equity Research

      Encompass Health (EHC) to construct an inpatient rehabilitation hospital with a capacity of 40 in Shiloh Illinois, which will be run as a joint venture with BJC HealthCare.

      Is DaVita HealthCare (DVA) Stock Undervalued Right Now?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      DVA vs. CHE: Which Stock Should Value Investors Buy Now?

      by Zacks Equity Research

      DVA vs. CHE: Which Stock Is the Better Value Option?

      New Strong Buy Stocks For November 5th

      by Zacks Equity Research

      Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

      The Zacks Analyst Blog Highlights: United Natural Foods, The Boston Beer Company, DaVita, Owens & Minor and Primo Water Corp

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: United Natural Foods, The Boston Beer Company, DaVita, Owens & Minor and Primo Water Corp

      The Zacks Analyst Blog Highlights: FedEx, Whirlpool, The Boston Beer Company, Laboratory Corporation of America and DaVita

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: FedEx, Whirlpool, The Boston Beer Company, Laboratory Corporation of America and DaVita

      Anirudha Bhagat headshot

      6 Stocks Near 52-Week Highs Poised to Appreciate Further

      by Anirudha Bhagat

      Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

      Acadia Healthcare (ACHC) Hits Fresh High: Is There Still Room to Run?

      by Zacks Equity Research

      Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.